Posted March 14th, 2018 by wpengine.
The first case against medical device maker C.R. Bard goes to trial this week in Phoenix, AZ.
Over 3,000 lawsuits are pending against Bard in the United States. Plaintiffs allege that Bard’s IVC filter is unsafe and has been linked to serious complications and death. The bellwether trial, Sherr-Una Booker v C.R. Bard Inc. and Bard Vascular Inc, is scheduled to begin on March 13, 2018. Booker has alleged that her complications include filter tilting, fracture and perforation according to DrugWatch.com. We will be watching closely to see how this trial unfolds and what the implications may be for other victims seeking legal recourse.
In a 2015 article, NBC news revealed that Bard continued to sell “G2” IVC filters for five years after it knew that the devices had potentially fatal flaws. It goes on to state that a Bard document “that includes data through 2010 showed the G2 series filters had more fractures, […]Read More